Keyword: National Institutes of Health (NIH)
Antibiotic R&D funding partnership CARB-X is putting up the cash to cut the time it takes to learn what pathogen is responsible for a case of sepsis.
Two studies uncover links between genes and brain-cell functioning that could provide new targets for therapies aimed at neurodegenerative diseases.
Two recent advances are focused on using engineered T cells and drug nanocrystals to combat the HIV “reservoirs” that hide in the body and cause the disease to re-emerge.
The NIH wants to speed up the development of gene-editing therapies—and is putting $190 million into a program to help make that happen.
Understanding how some helper T cells become killer T cells could lead to better vaccine design for HIV and hep C.
NIH scientists have modeled the 3D structure of DHHC enzymes, which modify EGFRs, which are implicated in a range of cancers.
UNC scientists unraveled the structure of an opioid receptor, which could allow for the design of painkillers that do not cause side effects.
Scientists at Walter Reed have developed a heroin vaccine to block the euphoric effects of opioids without interfering with other anti-addiction therapies.
The National Institutes of Health has tapped Fitbit to provide 10,000 devices for the All of Us research program.
Part of an international initiative, a pan-European observational study aims to improve clinical care of traumatic brain injury.